ME00828B - Upotreba hitozana za lečenje inflamatornih oboljenja noktiju - Google Patents

Upotreba hitozana za lečenje inflamatornih oboljenja noktiju

Info

Publication number
ME00828B
ME00828B MEP-2009-268A MEP26809A ME00828B ME 00828 B ME00828 B ME 00828B ME P26809 A MEP26809 A ME P26809A ME 00828 B ME00828 B ME 00828B
Authority
ME
Montenegro
Prior art keywords
chitosan
inflammatory diseases
chitosans
treatment
nail
Prior art date
Application number
MEP-2009-268A
Other languages
English (en)
French (fr)
Inventor
Federico Mailland
Original Assignee
Polichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38212471&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME00828(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Polichem Sa filed Critical Polichem Sa
Publication of ME00828B publication Critical patent/ME00828B/me

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Formulacije za nokte na bazi hitozana su od koristi za lečenje inflamatornih oboljenja kao što su psorijaza, atopični dermatitis i lichen planus. Hitozan je normalno u obliku derivata amino-polisahardoda, prioritetno u vodi rastvorljivog, kao što je hidroksipropil hitozan. Formulacija može biti lak za nokte, sprej, krem, mast, gel, losion ili pena i može imati sadržaj hitozana, derivata hitozana ili njihove soli od 0.1 do 25 tež. % u odnosu na ukupnu težinu formulacije.
MEP-2009-268A 2007-02-14 2008-02-07 Upotreba hitozana za lečenje inflamatornih oboljenja noktiju ME00828B (me)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07102338A EP1958639A1 (en) 2007-02-14 2007-02-14 Use of chitosans for the treatment of nail inflammatory diseases
PCT/EP2008/051479 WO2008098871A2 (en) 2007-02-14 2008-02-07 Use of chitosans for the treatment of nail inflammatory diseases

Publications (1)

Publication Number Publication Date
ME00828B true ME00828B (me) 2012-03-20

Family

ID=38212471

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2009-268A ME00828B (me) 2007-02-14 2008-02-07 Upotreba hitozana za lečenje inflamatornih oboljenja noktiju

Country Status (31)

Country Link
US (1) US8906881B2 (me)
EP (3) EP1958639A1 (me)
JP (3) JP2010518139A (me)
KR (1) KR101468479B1 (me)
CN (1) CN101641103B (me)
AR (1) AR065317A1 (me)
AU (1) AU2008214695B2 (me)
BR (1) BRPI0807596A2 (me)
CA (1) CA2676259C (me)
CL (1) CL2008000443A1 (me)
CO (1) CO6210818A2 (me)
CY (1) CY1113822T1 (me)
DK (1) DK2117565T3 (me)
EA (1) EA019539B1 (me)
EC (1) ECSP099631A (me)
ES (1) ES2394169T3 (me)
HK (1) HK1132919A1 (me)
HR (1) HRP20120915T1 (me)
IL (1) IL200091A (me)
MA (1) MA31237B1 (me)
ME (1) ME00828B (me)
MX (1) MX2009008514A (me)
MY (1) MY150502A (me)
NZ (1) NZ578937A (me)
PL (1) PL2117565T3 (me)
PT (1) PT2117565E (me)
RS (1) RS52620B (me)
SI (1) SI2117565T1 (me)
UA (1) UA101151C2 (me)
WO (1) WO2008098871A2 (me)
ZA (1) ZA200904975B (me)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7955418B2 (en) 2005-09-12 2011-06-07 Abela Pharmaceuticals, Inc. Systems for removing dimethyl sulfoxide (DMSO) or related compounds or odors associated with same
US9427419B2 (en) 2005-09-12 2016-08-30 Abela Pharmaceuticals, Inc. Compositions comprising dimethyl sulfoxide (DMSO)
WO2007033180A1 (en) 2005-09-12 2007-03-22 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds
US10201490B2 (en) * 2007-02-14 2019-02-12 Polichem Sa Use of chitosans for the treatment of nail inflammatory diseases
KR20110123739A (ko) * 2009-01-08 2011-11-15 알러간, 인코포레이티드 손발톱 성장을 증진시키기 위한 조성물
JP5947721B2 (ja) 2009-10-30 2016-07-06 アベラ ファーマスーティカルズ インコーポレイテッド 変形性関節症を治療するためのジメチルスルホキシド（ｄｍｓｏ）およびメチルスルホニルメタン（ｍｓｍ）製剤
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
EA033767B1 (ru) * 2014-06-10 2019-11-22 Makhbuba Nabi Kyzy Velieva Средство против выпадения волос на основе лекарственных растений
PL233616B1 (pl) 2017-08-10 2019-11-29 Podopharm Spolka Z Ograniczona Odpowiedzialnoscia Preparat do paznokci, dloni i stop oraz sposob wytwarzania tego preparatu
KR102511613B1 (ko) * 2019-09-23 2023-03-17 포항공과대학교 산학협력단 키토산을 포함하는 면역억제용 조성물 및 이의 용도

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE378109B (me) 1972-05-19 1975-08-18 Bofors Ab
DE3541305A1 (de) 1985-11-22 1987-05-27 Wella Ag Kosmetische mittel auf der basis von n-hydroxypropylchitosanen, neue n-hydroxypropyl-chitosane sowie verfahren zu ihrer herstellung
JPH08245401A (ja) * 1995-03-14 1996-09-24 Osamu Hatanaka 皮膚保護剤
SE9604610D0 (sv) * 1996-12-16 1996-12-16 Noviscens Ab Medical composition
US7147854B2 (en) * 1997-06-23 2006-12-12 Yes Biotech Laboratories Ltd. Topical treatment of psoriasis using neutralizing antibodies to interleukin-8
JP4185173B2 (ja) 1997-08-07 2008-11-26 株式会社ノエビア 両親媒性キトサン誘導体及びこれを含有する皮膚外用剤
CA2343284C (en) * 1998-09-10 2008-11-18 Ipr-Institute For Pharmaceutical Research Ag Topical application products
DE19911056B9 (de) 1999-03-12 2005-09-08 Biotec Asa Kosmetische Zubereitungen und deren Verwendung
JP2001055335A (ja) * 1999-08-18 2001-02-27 Toshio Sato アレルギー性皮膚疾患治療剤
JP2001131030A (ja) * 1999-11-08 2001-05-15 Kureha Chem Ind Co Ltd 発毛促進剤
DE10035991A1 (de) 2000-07-24 2002-02-14 Polichem Sa Nagellackzusammensetzung
NO310176B1 (no) 2000-11-13 2001-06-05 Wadlund As Sammensetning for hud som inneholder kitosan-konjugert CLA og kitosankonjugert vitamin A eller et <beta>-cyklodekstrin-konjugertvitamin A samt fremgangsmåte for fremstilling og anvendelse avdenne
KR20020048534A (ko) 2000-12-18 2002-06-24 안병로 파라핀 왁스를 유효성분으로 하는 피부 맛사지 팩제
SE0100166D0 (sv) 2001-01-22 2001-01-22 Tacton Systems Ab Configuration system
KR100457546B1 (ko) 2001-05-02 2004-11-18 주식회사 바이오프로젠 폴리프럭토오스 또는 그 유도체를 이용한 미소구 및 그제조방법
GB0126923D0 (en) 2001-11-09 2002-01-02 Procter & Gamble Chitosan compositions
ATE411032T1 (de) * 2001-12-14 2008-10-15 Dnp Canada Inc Verwendungen von chitosanoligosacchariden
KR100470753B1 (ko) * 2003-01-09 2005-03-10 주식회사 자광 수용성 천연필름과 그의 제조방법
JP2004231604A (ja) 2003-01-31 2004-08-19 Hamamatsu Kagaku Gijutsu Kenkyu Shinkokai 担体シートおよび徐放性製剤ならびにそれらの製法
EP1491202A1 (en) * 2003-06-23 2004-12-29 Polichem S.A. Nail restructuring compositions for topical application
US20050112151A1 (en) 2003-11-20 2005-05-26 Horng Liou L. Skin adherent hydrogels
RU2258516C1 (ru) * 2004-01-20 2005-08-20 Государственное Образовательное Учреждение "Красноярская Государственная Медицинская Академия Министерства Здравоохранения Российской Федерации" Способ лечения красного плоского лишая
JP2005306746A (ja) 2004-04-19 2005-11-04 Jiyugaoka Clinic 顔面用シワ治療剤
US20060078580A1 (en) * 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
JP4804770B2 (ja) * 2005-02-28 2011-11-02 株式会社アリミノ ヘアーコンディショニング剤およびその使用方法
WO2006111426A1 (en) * 2005-04-19 2006-10-26 Galderma S.A. Composition of film-forming solution type, comprising vitamin d or a derivative thereof and a corticosteroid, and use thereof in dermatology
WO2006134614A1 (en) * 2005-06-14 2006-12-21 Genis Ehf. Compositions of partially deacetylated chitin derivatives
FR2892023B1 (fr) * 2005-10-14 2009-09-25 Galderma Sa Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale
EP1842545A1 (en) * 2006-04-04 2007-10-10 Marinomed Biotechnologie GmbH Anti-inflammatory polymer
DE102006049585A1 (de) * 2006-10-22 2008-04-24 Susilo, Rudy, Dr. Nagellack für kosmetische und medizinische Anwendungen

Also Published As

Publication number Publication date
RS52620B (en) 2013-06-28
EP2117565A2 (en) 2009-11-18
ES2394169T3 (es) 2013-01-23
AU2008214695A1 (en) 2008-08-21
IL200091A0 (en) 2010-04-15
US20100104670A1 (en) 2010-04-29
IL200091A (en) 2013-05-30
JP2010518139A (ja) 2010-05-27
WO2008098871A2 (en) 2008-08-21
CY1113822T1 (el) 2016-07-27
EA019539B1 (ru) 2014-04-30
PT2117565E (pt) 2013-01-07
AR065317A1 (es) 2009-05-27
PL2117565T3 (pl) 2013-03-29
KR20090121302A (ko) 2009-11-25
SI2117565T1 (sl) 2013-01-31
HRP20120915T1 (hr) 2012-12-31
ZA200904975B (en) 2010-09-29
KR101468479B1 (ko) 2014-12-05
EP2117565B1 (en) 2012-10-17
MY150502A (en) 2014-01-30
JP6035292B2 (ja) 2016-11-30
HK1132919A1 (en) 2010-03-12
CN101641103B (zh) 2013-05-15
MX2009008514A (es) 2009-08-20
CA2676259A1 (en) 2008-08-21
CO6210818A2 (es) 2010-10-20
UA101151C2 (ru) 2013-03-11
CN101641103A (zh) 2010-02-03
AU2008214695A2 (en) 2009-09-03
EP2455086A1 (en) 2012-05-23
WO2008098871A3 (en) 2008-10-09
MA31237B1 (fr) 2010-03-01
ECSP099631A (es) 2009-12-28
EP1958639A1 (en) 2008-08-20
BRPI0807596A2 (pt) 2014-07-22
JP2014208709A (ja) 2014-11-06
JP2016188252A (ja) 2016-11-04
CA2676259C (en) 2015-07-14
CL2008000443A1 (es) 2008-08-22
US8906881B2 (en) 2014-12-09
AU2008214695B2 (en) 2013-10-03
EA200901113A1 (ru) 2010-02-26
DK2117565T3 (da) 2012-11-19
NZ578937A (en) 2012-05-25

Similar Documents

Publication Publication Date Title
ME00828B (me) Upotreba hitozana za lečenje inflamatornih oboljenja noktiju
WO2012085523A3 (en) Skin sanitizer compositions comprising alcohol based emulsion
WO2006063864A3 (en) Compositions for preventing, reducing or treating keratinocyte-mediated inflammation
DOP2013000105A (es) Derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituidos con aminoalcoholes que son de utilidad para tratar trastornos hiperproliferativos y enfermedades asociadas a la angiogénesis
WO2009115517A3 (en) Pyridines and pyrazines as inhibitors of pi3k
MY157944A (en) Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associat ed with angiogenesis
MX2010001031A (es) Composiciones preservativas para paños limpiadores humedos.
NO20072895L (no) Topiske sammensetninger inneholdende myrica gale olje
ATE398995T1 (de) Hautpflegemittel die salicylsäure enthalten
HRP20110667T1 (hr) Upotreba kitozana radi ubrzavanja rasta noktiju
WO2012163928A3 (en) Topical wash composition for use in acne patients
WO2009090624A3 (es) Gel de quitosano para aplicaciones dermatológicas, proceso de obtención y uso del mismo
NZ703808A (en) Topical transdermal dexmedetomidine compositions and methods of use thereof
WO2012176166A3 (en) Cleaning composition comprising a gelling agent and a foaming surfactant
JP2010518138A5 (me)
WO2014023895A3 (fr) Inhibition de l&#39;adhesion de micro-organismes pathogenes par un sucrose stearate et/ou de sorbitan dans le traitement cosmetique de l&#39;atopie cutanee
RU2009149607A (ru) Увлажняющий агент для кожи и его применение
WO2008004165A3 (en) Use of c-glycoside derivatives as pro-desquamating active agents
ITMI20031291A1 (it) Uso di acido ialuronico per la preparazione di composizioni per il trattamento di afte del cavo orale.
WO2014178789A9 (en) Topical composition and carrier for administration of pharmaceutically or cosmetically active ingredients
MY160377A (en) Topical pharmaceutical compositions
CN102784073A (zh) 天然护发素
WO2007082864A3 (en) Use of chavicol as an antiseptic
BRPI0415225A (pt) composições tópicas compreendendo telmesteìna para o tratamento de distúrbios dermatológicos
WO2009007341A3 (en) Topical composition containing adapalene for the treatment of keratini zation disorders